GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acusphere Inc (OTCPK:ACUS) » Definitions » Cash And Cash Equivalents

Acusphere (Acusphere) Cash And Cash Equivalents : $4.11 Mil (As of Sep. 2008)


View and export this data going back to 2003. Start your Free Trial

What is Acusphere Cash And Cash Equivalents?

Acusphere's quarterly cash and cash equivalents declined from Mar. 2008 ($24.73 Mil) to Jun. 2008 ($11.98 Mil) but then stayed the same from Jun. 2008 ($11.98 Mil) to Sep. 2008 ($4.11 Mil).

Acusphere's annual cash and cash equivalents increased from Dec. 2005 ($51.11 Mil) to Dec. 2006 ($59.75 Mil) but then declined from Dec. 2006 ($59.75 Mil) to Dec. 2007 ($26.10 Mil).


Acusphere Cash And Cash Equivalents Historical Data

The historical data trend for Acusphere's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acusphere Cash And Cash Equivalents Chart

Acusphere Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Cash And Cash Equivalents
Get a 7-Day Free Trial 54.56 45.18 51.11 59.75 26.10

Acusphere Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.51 26.10 24.73 11.98 4.11

Acusphere Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Acusphere  (OTCPK:ACUS) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Acusphere Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Acusphere's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Acusphere (Acusphere) Business Description

Traded in Other Exchanges
N/A
Address
99 Hayden Avenue, Suite 385, Lexington, MA, USA, 02421
Acusphere Inc is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology.
Executives
Martyn D Greenacre director 41 MOORES ROAD, FRAZER PA 19355
Garen G Bohlin director C/O PRAECIS PHARMACEUTICALS INC, 830 WINTER STREET, WALTHAM MA 02451
Sandra L Fenwick director C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Frederick W Ahlholm officer: VP Finance C/O MINERVA NEUROSCIENCES, INC., 1601 TRAPELO ROAD, SUITE 286, WALTHAM MA 02451
John F Thero other: Former Senior VP/CFO C/O AMARIN PHARMA, INC., 1430 ROUTE 6, BEDMINSTER NJ 07921
Kate Mitchell director 950 TOWER LANE, STE 700, FOSTER CITY CA 94404
Bank Of America Corp /de/ 10 percent owner BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE NC 28255
Bank Of America Na 10 percent owner 100 N. TRYON STREET, CHARLOTTE NC 28255
Nb Holdings Corp 10 percent owner 100 NORTH TRYON STREET, CHARLOTTE NC 28255
Terrance Mcguire director C/O POLARIS VENTURE PARTNERS LP, 1000 WINTER STREET, SUITE 3350, WALTHAM MA 02154

Acusphere (Acusphere) Headlines

No Headlines